Reply to Comment on: Rethinking the Hydroxychloroquine Dosing and Retinopathy Screening Guidelines

Am J Ophthalmol. 2021 Feb:222:400-401. doi: 10.1016/j.ajo.2020.09.015. Epub 2020 Nov 20.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antirheumatic Agents* / adverse effects
  • Humans
  • Hydroxychloroquine / adverse effects
  • Mass Screening
  • Retinal Diseases* / chemically induced
  • Retinal Diseases* / diagnosis
  • Retinal Diseases* / drug therapy

Substances

  • Antirheumatic Agents
  • Hydroxychloroquine